Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 1.00 |
| ▸ | EP300 | Q09472 | 3/20 | 0.96 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.96 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.54 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.54 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.54 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.52 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.52 |
| ▸ | NQO1 | P15559 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | FGB | P02675 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6155452 | 0.98 | EP300 (1.00) | IDO1EP300KAT8ALDH1A1TDP1 | |
| Chlorobenzene SCHEMBL8843354 | 0.89 | IDO1 (0.79) | IDO1EP300KAT8ALDH1A1TDP1 | |
| SCHEMBL485125 | 0.86 | IDO1 (0.76) | IDO1EP300KAT8ALDH1A1TDP1 | |
| SCHEMBL30881664 | 0.86 | IDO1 (0.76) | IDO1EP300KAT8ALDH1A1TDP1 | |
| SCHEMBL419307 | 0.85 | IDO1 (0.73) | IDO1EP300KAT8ALDH1A1IMPDH2 | |
| SCHEMBL29380721 | 0.85 | IDO1 (0.73) | IDO1EP300KAT8ALDH1A1IMPDH2 | |
| SCHEMBL4687323 | 0.81 | IDO1 (0.68) | IDO1EP300KAT8ALDH1A1TDP1 | |
| SCHEMBL5747547 | 0.79 | NQO1 (0.77) | IDO1EP300KAT8ALDH1A1TDP1 | |
| SCHEMBL11618652 | 0.78 | IDO1 (0.64) | IDO1EP300KAT8ALDH1A1TDP1 | |
| SCHEMBL12019841 | 0.78 | IDO1 (0.64) | IDO1EP300KAT8ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060281897-A1 | Potentialization of the activation of high molecular weight prodrugs | DIATOS S.A. (FR) | 2006-12-14 | — | — | US | claimed |
| US-20250161501-A1 | Radiolabeled Compounds for Imaging of Fibroblast Activation Protein (FAP) and Treatment of FAP-Related Disorders | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2025-05-22 | — | — | US | disclosed |
| CN-113801087-B | Benzo-six-membered ring derivatives as DPP-4 inhibitors and uses thereof | 山东百极地长制药有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-118221915-A | Hole transport material doped with modified fluorene polymer containing oligoether chain, preparation and application thereof | 华南理工大学 | 2024-06-21 | — | — | CN | disclosed |
| CN-113801088-B | Benzo six-membered ring derivative and application thereof | 山东百极地长制药有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117903781-A | Visible light excited organic long afterglow material, three-dimensional structure, preparation method and application thereof | 西北工业大学 | 2024-04-19 | — | — | CN | disclosed |
| WO-2023133645-A1 | RADIOLABELED COMPOUNDS FOR IMAGING OF FIBROBLAST ACTIVATION PROTEIN (FAP) AND TREATMENT OF FAP-RELATED DISORDERS | PROVINCIAL HEALTH SERVICES AUTHORITY (CA) | 2023-07-20 | — | — | WO | disclosed |
| CN-113801088-A | Benzo-six-membered ring derivative and application thereof | 山东百极地长制药有限公司 | 2021-12-17 | — | — | CN | disclosed |
| CN-113801087-A | Benzo-hexatomic ring derivative as DPP-4 inhibitor and application thereof | 山东百极地长制药有限公司 | 2021-12-17 | — | — | CN | disclosed |
| WO-2021249566-A1 | BENZO SIX-MEMBERED RING DERIVATIVE AND USE THEREOF | 山东百极地长制药有限公司 | 2021-12-16 | — | — | WO | disclosed |
| US-4234483-A | COLORFASTNESS; BRIGHTNESS | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1980-11-18 | — | — | US | disclosed |
| US-4171221-A | NONSILVER PHOTOGTAPHY | EASTMAN KODAK COMPANY (US) | 1979-10-16 | — | — | US | disclosed |
| US-4158542-A | Acyldihydroxybenzene azo dyes for metallized polyolefins | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1979-06-19 | — | — | US | disclosed |
| US-4118383-A | COLORFAST ON POLYESTER AND METALLIZED POLYPROPYLENE FIBERS | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1978-10-03 | — | — | US | disclosed |
| US-4089850-A | FOR METAL MODIFIED POLYPROPYLENE | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1978-05-16 | — | — | US | disclosed |
| US-4066388-A | DISAZO DYES DERIVED FROM 1-ACYL-2,4-DIHYDROXYBENZENES AND METALLIZED POLYOLEFIN DYED THEREWITH | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1978-01-03 | — | — | US | disclosed |
| US-4056519-A | TRIPEPTIDYL-4-METHOXY-2-NAPHTHYLAMIDE | ELI LILLY AND COMPANY (US) | 1977-11-01 | — | — | US | disclosed |
| US-4022799-A | DYEING, PRINTING OF NATURAL AND SYNTHETIC MATERIALS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-05-10 | — | — | US | disclosed |
| US-4001253-A | NAPHTHOLACTAM DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-01-04 | — | — | US | disclosed |
| US-3950347-A | NAPHTHOLACTAM DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161501-A1 | Radiolabeled Compounds for Imaging of Fibroblast Activation Protein (FAP) and Treatment of FAP-Related Disorders | FAP, FIBP, FGFR1 | IDO1 4279/4885EP300 685/4885KAT8 3912/4885 |
| US-20060281897-A1 | Potentialization of the activation of high molecular weight prodrugs | CD44, MMP12, FOLH1 | IDO1 2299/4885EP300 2397/4885KAT8 3978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.